Letter to the editor. Women with HER2-positive metastatic breast cancer have significantly longer survival after diagnosis of brain metastasis(BM) than those with HER2-negative disease
- PMID: 19346820
- DOI: 10.1097/COC.0b013e318187ddaa
Letter to the editor. Women with HER2-positive metastatic breast cancer have significantly longer survival after diagnosis of brain metastasis(BM) than those with HER2-negative disease
Comment on
-
Extended survival in women with brain metastases from HER2 overexpressing breast cancer.Am J Clin Oncol. 2008 Jun;31(3):250-4. doi: 10.1097/COC.0b013e31815a43c4. Am J Clin Oncol. 2008. PMID: 18525303
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous